Marksans Pharma LimitedNSE: MARKSANS

Press Release Jan 23 2023

· Issued by Marksans Pharma Limited

Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated January 23, 2023, titled "Marksans Pharma Limited announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution.".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases